Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas is a research paper published in Scientific Reports (2021). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institue on Deafness and Other Communication Disorders
Grant: Intramural Research Program, projects ZIA-DC-000016, 73 and 74
Intramural NIH HHS
Grant: ZIA DC000016
National Institutes of Health
Grant: 1ZIADC000016-26
NF-kappaB in pathogenesis and therapy of head and neck cancer
National Institutes of Health
FWCI
0.24
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals